<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Surg.</journal-id>
<journal-title>Frontiers in Surgery</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Surg.</abbrev-journal-title>
<issn pub-type="epub">2296-875X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fsurg.2021.647656</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Surgery</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Current Management of Post-radical Prostatectomy Urinary Incontinence</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Rahnama&#x00027;i</surname> <given-names>Mohammad S.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/238930/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Marcelissen</surname> <given-names>Tom</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Geavlete</surname> <given-names>Bogdan</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1215140/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Tutolo</surname> <given-names>Manuela</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>H&#x000FC;sch</surname> <given-names>Tanja</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Urology Department, Uniklinik  RWTH Aachen</institution>, <addr-line>Aachen</addr-line>, <country>Germany</country></aff>
<aff id="aff2"><sup>2</sup><institution>Maastricht University Medical Center (MUMC&#x0002B;)</institution>, <addr-line>Maastricht</addr-line>, <country>Netherlands</country></aff>
<aff id="aff3"><sup>3</sup><institution>Bucharest University Emergency Hospital</institution>, <addr-line>Bucharest</addr-line>, <country>Romania</country></aff>
<aff id="aff4"><sup>4</sup><institution>Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele</institution>, <addr-line>Milan</addr-line>, <country>Italy</country></aff>
<aff id="aff5"><sup>5</sup><institution>Mainz University Hospital</institution>, <addr-line>Mainz</addr-line>, <country>Germany</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Luis Alex Kluth, University Hospital Frankfurt, Germany</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Juan Gomez Rivas, Hospital Cl&#x000ED;nico San Carlos, Spain; Jens Hansen, Vivantes Auguste Viktoria Clinic, Germany; Tim Alexander Ludwig, University Medical Center Hamburg-Eppendorf, Germany</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Mohammad S. Rahnama&#x00027;i <email>sajjad_r&#x00040;yahoo.com</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Genitourinary Surgery, a section of the journal Frontiers in Surgery</p></fn></author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>04</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>8</volume>
<elocation-id>647656</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>12</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>03</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2021 Rahnama&#x00027;i, Marcelissen, Geavlete, Tutolo and H&#x000FC;sch.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Rahnama&#x00027;i, Marcelissen, Geavlete, Tutolo and H&#x000FC;sch</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license></permissions>
<abstract><p>Prostate cancer is the second most common cancer in men worldwide. Radical prostatectomy and radiation beam therapy are the most common treatment options for localized prostate cancer and have different associated complications. The etiology of post prostatectomy incontinence is multifactorial. There is evidence in the literature that anatomic support and pelvic innervation are important factors in the etiology of post-prostatectomy incontinence. Among the many surgical and technical factors proposed in the literature, extensive dissection during surgery, damage to the neurovascular bundle and the development of postoperative fibrosis have a substantial negative impact on the continence status of men undergoing RP. Sparing of the bladder neck and anterior, and possibly posterior, fixation of the bladder-urethra anastomosis are associated with better continence rates. Overactive bladder syndrome (OAB) is multifactorial and the exact role of prostate surgery in the development of OAB is still under debate. There are several variables that could contribute to detrusor overactivity. Detrusor overactivity in patients after radical prostatectomy has been mainly attributed to a partial denervation of the bladder during surgery. However, together with bladder denervation, other hypotheses, such as the urethrovesical mechanism, have been described. Although there is conflicting evidence regarding the importance of conservative treatment after post-prostatectomy urinary incontinence, pelvic floor muscle training (PFMT) is still considered as the first treatment choice. Duloxetin, either alone or in combination with PFMT, may hasten recovery of urinary incontinence but is often associated with severe gastrointestinal and central nervous side effects. However, neither PFMT nor duloxetine may cure male stress urinary incontinence. The therapeutic decision and the chosen treatment option must be individualized for each patient according to clinical and social factors. During the recent years, the development of new therapeutic choices such as male sling techniques provided a more acceptable management pathway for less severe forms of urinary incontinence related to radical prostatectomy. Following this perspective, technological improvements and the emergence of new dedicated devices currently create the premises for a continuously positive evolution of clinical outcomes in this particular category of patients.</p></abstract>
<kwd-group>
<kwd>prostate cancer</kwd>
<kwd>incontinence (male)</kwd>
<kwd>detrusor activity</kwd>
<kwd>stress incontinence</kwd>
<kwd>prostatectomy</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="77"/>
<page-count count="10"/>
<word-count count="7409"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Prostate cancer is the second most common cancer in men worldwide, affecting &#x0007E;1.1 million men per year (<xref ref-type="bibr" rid="B1">1</xref>). Radical prostatectomy (rPR) and radiation beam therapy are comparable treatment options for localized prostate cancer (<xref ref-type="bibr" rid="B2">2</xref>) whereas treatment associated complications and incidences differ significantly.</p>
<p>Male stress urinary incontinence (SUI) has a predominantly iatrogenic cause after radical prostatectomy (<xref ref-type="bibr" rid="B3">3</xref>). It is defined by the complaint of involuntary leakage on effort or exertion or on sneezing, or coughing (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). The mechanism for post-radical prostatectomy incontinence remains unclear (<xref ref-type="bibr" rid="B6">6</xref>), however, several hypothesis have been discussed. Despite direct injury to the internal sphincter itself, injury to the external rhabdosphincter or its shortened lengthwise (<xref ref-type="bibr" rid="B7">7</xref>), injuries to the supporting structures of the urethra (<xref ref-type="bibr" rid="B7">7</xref>), lesions to the nerve supply (<xref ref-type="bibr" rid="B6">6</xref>) or even detrusor underactivity (<xref ref-type="bibr" rid="B8">8</xref>) may impair continence.</p>
<p>The incidence of post-radical prostatectomy incontinence has become an increasingly common urological problem with a prevalence of 2.5&#x02013;90% (<xref ref-type="bibr" rid="B9">9</xref>) depending on the definition for urinary continence. In a recent prospective non-randomized trial comparing open retropubic rPR and robotic assisted rPR including a total of 2,625 men, urinary incontinence defined by no change pad in 24 h after 12 month follow-up was 21.3 and 20.2% for robotic-assisted and open rPR, respectively (<xref ref-type="bibr" rid="B10">10</xref>). A meta-analysis did not identify a significant difference of urinary continence in comparison between open retropubic and robot assisted rPR (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). A prospective randomized trial comparing laparoscopic and robotic-assisted rPR demonstrated significant better continence rates for robotic-assisted than laparoscopic rPR (95.0 vs. 83.3%) (<xref ref-type="bibr" rid="B13">13</xref>). A meta-analysis identified evidence for improved continence rates with robotic-assisted in comparison to laparoscopic rPR accordingly (<xref ref-type="bibr" rid="B14">14</xref>). <xref ref-type="table" rid="T1">Table 1</xref> present the continence rates after radical prostatectomy reported by selected prospective trials.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Continence rates after radical prostatectomy of selected clinical trials.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>References</bold></th>
<th valign="top" align="center"><bold>Year</bold></th>
<th valign="top" align="left"><bold>Study design</bold></th>
<th valign="top" align="center"><bold>Number of patients</bold></th>
<th valign="top" align="left"><bold>Follow-up time</bold></th>
<th valign="top" align="left"><bold>Continence definition</bold></th>
<th valign="top" align="left"><bold>Urinary continence, n/N (%)</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Haglind et al. (<xref ref-type="bibr" rid="B10">10</xref>)</td>
<td valign="top" align="center">2015</td>
<td valign="top" align="left">Prospective, non-randomized</td>
<td valign="top" align="center">2,625</td>
<td valign="top" align="left">12 months</td>
<td valign="top" align="left">&#x0003C;1 pad/24 h</td>
<td valign="top" align="left">RALP 366/1847 (21.3) <break/> RRP 144/778 (20, 2)</td>
</tr>
<tr>
<td valign="top" align="left">Choo et al. (<xref ref-type="bibr" rid="B15">15</xref>)</td>
<td valign="top" align="center">2012</td>
<td valign="top" align="left">Prospective, non-randomized</td>
<td valign="top" align="center">253</td>
<td valign="top" align="left">24 months</td>
<td valign="top" align="left">0&#x02013;1 pad/24 h</td>
<td valign="top" align="left">RALP 73/77 (95) <break/> RRP 172/176 (98)</td>
</tr>
<tr>
<td valign="top" align="left">Rocco et al. (<xref ref-type="bibr" rid="B16">16</xref>)</td>
<td valign="top" align="center">2009</td>
<td valign="top" align="left">Prospective<break/> non-randomized <break/> Matched to historical control group</td>
<td valign="top" align="center">240</td>
<td valign="top" align="left">12 months</td>
<td valign="top" align="left">0&#x02013;1 pad/24 h</td>
<td valign="top" align="left">RALP 77/79 (97) <break/> RRP 191/217 (88)</td>
</tr>
<tr>
<td valign="top" align="left">Son et al. (<xref ref-type="bibr" rid="B17">17</xref>)</td>
<td valign="top" align="center">2013</td>
<td valign="top" align="left">Prospective<break/> non-randomized</td>
<td valign="top" align="center">258</td>
<td valign="top" align="left">12 months</td>
<td valign="top" align="left">0&#x02013;1 pad/24 h</td>
<td valign="top" align="left">RALP 146/146 (100) <break/> RRP /112 (98.2)</td>
</tr>
<tr>
<td valign="top" align="left">Kim et al. (<xref ref-type="bibr" rid="B18">18</xref>)</td>
<td valign="top" align="center">2018</td>
<td valign="top" align="left">Prospective<break/> non-randomized</td>
<td valign="top" align="center">529</td>
<td valign="top" align="left">12 months</td>
<td valign="top" align="left">0 pads/3 days and an absence of any unwanted urine leakage</td>
<td valign="top" align="left">RALP none or unilateral nerv-sparing 191/460 (41.5) <break/> RALP bilateral nerv-sparing 269/460 (58.5)</td>
</tr>
<tr>
<td valign="top" align="left">Olsson et al. (<xref ref-type="bibr" rid="B19">19</xref>)</td>
<td valign="top" align="center">2001</td>
<td valign="top" align="left">Prospective<break/> non-randomized</td>
<td valign="top" align="center">228</td>
<td valign="top" align="left">12 months</td>
<td valign="top" align="left">0 pads/24 h</td>
<td valign="top" align="left">LRP 29/37 (78.4)</td>
</tr>
<tr>
<td valign="top" align="left">Porpiglia et al. (<xref ref-type="bibr" rid="B13">13</xref>)</td>
<td valign="top" align="center">2012</td>
<td valign="top" align="left">Prospective<break/> randomized</td>
<td valign="top" align="center">120</td>
<td valign="top" align="left">12 months</td>
<td valign="top" align="left">0&#x02013;1 pad/24 h</td>
<td valign="top" align="left">RALP 57/60 (95.0) <break/> LRP 50/60 (83.3)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>RALP, Robotic assisted laparoscopic radical prostatectomy; RRP, open retropubic radical prostatectomy; LRP, laparoscopic radical Prostatectomy</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>Importantly, the impact of urinary incontinence to affected patients is substantial and include stigmatization and significant reduction of quality of life (<xref ref-type="bibr" rid="B20">20</xref>). In addition, the cost burden of urinary incontinence is currently estimated between $19 and $32 billion in the USA (<xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>Overactive bladder (OAB), with or without urinary incontinence, can also occur after radical prostatectomy and is an underestimated cause for urinary incontinence after radical prostatectomy. However, so far there is a lack of robust data for its incidence.</p>
<p>In this non-systematic review, we provide an overview on pathophysiology and current treatment options of male stress urinary incontinence after radical prostatectomy.</p></sec>
<sec id="s2">
<title>Pathophysiology</title>
<p>There are different factors responsible for the post-rPR urinary incontinence. The most well-known factors include the changes that occur in the anatomy, the preoperative bladder function as well as the operation technique and the experience of the surgeon (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). In addition, the anatomic support and the pelvic innervation have been identified as important contributors to post rPR continence (<xref ref-type="bibr" rid="B21">21</xref>). Among the many surgical and technical factors proposed in the literature as contributing to the development of urinary incontinence following rPR, extensive dissection during surgery, damage to the neurovascular bundle, and the development of postoperative fibrosis have a substantial negative impact on the continence status of men undergoing rPR. Sparing of the bladder neck and anterior, and possibly posterior, fixation of the bladder-urethra anastomosis are associated with better continence rates (<xref ref-type="bibr" rid="B22">22</xref>).</p>
<p>Continence is generally facilitated by the combination of the action of the detrusor muscle, the proximal intrinsic sphincter, the rhabdosphincter (<xref ref-type="bibr" rid="B23">23</xref>), and the urethral suspensory mechanism composed of pubourethral ligaments (<xref ref-type="bibr" rid="B24">24</xref>). After rPR, the proximal urethral sphincter, the suspensory ligaments as well as parts of the proximal intrinsic sphincter are removed. As a consequence, post rPR urinary continence is largely dependent on the rhabdosphincter (<xref ref-type="bibr" rid="B25">25</xref>). In addition, the pudendal nerve fibers that innervate the rhabdosphincter are damaged during the operation which has functional implications. This has been studied by transurethral ultrasound, that has shown thinning or atrophy as well as impaired contractility of the rhabdosphincter (<xref ref-type="bibr" rid="B25">25</xref>). Moreover, the innervation of the detrusor muscle and trigonum are impair which leads to a decreased detrusor contractility and poor bladder compliance (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). The most predominant finding in urodynamic measurements is the sphincteric incontinence (<xref ref-type="bibr" rid="B28">28</xref>). On the other hand, intrinsic detrusor dysfunction and overactivity or impaired detrusor contractility, and altered detrusor compliance play a role in the post rPR continence (<xref ref-type="bibr" rid="B29">29</xref>). Preoperative urodynamic abnormalities have been observed to be present in 41% of patients, with half of them having detrusor overactivity (<xref ref-type="bibr" rid="B28">28</xref>).</p>
<p>About 50% of patients have preoperative impaired bladder compliance and impaired detrusor contractility and 47% <italic>de novo</italic> postoperative changes (<xref ref-type="bibr" rid="B30">30</xref>). Urodynamic studies carried out 1 year after rPR have shown sphincteric incontinence as the most common finding, which was responsible for about 88&#x02013;100% urinary incontinence after rPR (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>). About a third of the patients had an intrinsic sphincter deficiency as the single cause of their urinary incontinence (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B32">32</xref>). Furthermore, detrusor overactivity and impaired bladder contractility were each found in up to a 30% of the cases (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B32">32</xref>). However, in &#x0003C;9% of the cases, these findings were the only urodynamic finding (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B32">32</xref>). In one out of five patients, bladder outlet obstruction was found, but this was the sole urodynamic finding in only 1% of the cases (<xref ref-type="bibr" rid="B31">31</xref>). Delayed first sensation (42%), mixed urgency-urge incontinence (48%), and decreased bladder capacity (&#x0003C; 300 mL) (41%) were the other findings on urodynamic measurements after rPR (<xref ref-type="bibr" rid="B26">26</xref>). It must also be stressed that, a highly well-established predictor of functional outcomes is the surgeon. It is well-known that patients treated in high volume centers and in experienced hands, are more likely to be dry. When reviewing different series, the absence of this variable could represent a limitation since, in some cases, an individual surgeon&#x00027;s outcomes may be much better, or worse, than any nomogram prediction. Better urinary continence recovery results can be expected by patients who undergo rPR performed by a surgeon with greater experience (<xref ref-type="bibr" rid="B33">33</xref>). An annual surgical case load of &#x0003E;50 cases/year results in improved continence recovery outcomes following rPR (<xref ref-type="bibr" rid="B33">33</xref>).</p></sec>
<sec id="s3">
<title>OAB and Urgency Incontinence</title>
<p>In the context of management of post-rPR OAB syndrome, it is important to understand its underlying pathophysiological mechanism (<xref ref-type="bibr" rid="B34">34</xref>). Since OAB is multifactorial (<xref ref-type="bibr" rid="B35">35</xref>), the exact role of prostate surgery in the development of OAB is still under debate as, after rPR, there are several variables that could contribute to detrusor overactivity.</p>
<p>Detrusor overactivity in patients after radical prostatectomy has been mainly attributed to a partial denervation of the bladder during surgery (<xref ref-type="bibr" rid="B30">30</xref>). However, together with bladder denervation, other hypotheses, such as the urethrovesical mechanism, have been described.</p>
<p>It has been demonstrated that urethral afferents are activated by urethral perfusion (<xref ref-type="bibr" rid="B36">36</xref>) and they could modulate the micturition reflex via pudendal and pelvic afferent and efferent signals, causing bladder contraction. This has been described as urethrovesical mechanism (<xref ref-type="bibr" rid="B37">37</xref>&#x02013;<xref ref-type="bibr" rid="B39">39</xref>).</p>
<p>In a recent study, Mastukawa et al. identified that low maximum urethral closure pressure at baseline and its decrease postoperatively were strong predictors of <italic>de novo</italic> post-rPR OAB underlying the role of the intrinsic sphincter deficiency on the pathophysiology of OAB (<xref ref-type="bibr" rid="B40">40</xref>).</p>
<p>In contrast, detrusor underactivity may cause OAB syndrome as well, which seems contradictory at the first glance. Bladder underactivity may affect up to 40% of patients after radical prostatectomy mostly due to denervation (<xref ref-type="bibr" rid="B41">41</xref>).</p>
<p>Bladder outlet obstruction is a known cause of OAB. The obstruction after RP is mainly caused by bladder neck contracture and urethral stricture due to the anastomosis of the bladder neck with the urethra, which has an incidence up to 20% (<xref ref-type="bibr" rid="B42">42</xref>). BOO causes damage to the smooth muscle demonstrating histological changes in the bladder wall causing spontaneous myogenic contractions (<xref ref-type="bibr" rid="B43">43</xref>). Therefore, the presence of infravesical obstruction due to urethral stricture or bladder neck contracture must be excluded.</p></sec>
<sec id="s4">
<title>Predicting Urinary Incontinence After Radical Prostatectomy</title>
<p>Damage to the urethral sphincter complex, the surrounding structures, or their innervation leads to higher rates of urinary incontinence after rPR. In addition, certain biological factors and parameters known preoperatively, including older age, higher BMI, pre-existing LUTS, lower motor unit lesion, and functional bladder changes, have been identified to have a negative impact on continence rates after rPR (<xref ref-type="bibr" rid="B22">22</xref>).</p>
<p>Recently, a preoperative model was presented to predict incontinence before rPR (<xref ref-type="fig" rid="F1">Figure 1</xref>) (<xref ref-type="bibr" rid="B44">44</xref>). According this nomogram, high risk for biochemical recurrence, adjuvant radiotherapy, lower results in the validated quality of life questionnaire EORCT QLQ-C30/QoL, higher sum score of the validated questionnaire International Consultation of Incontinence Questionnaire&#x02014;Urinary Incontinence&#x02014;Short form (ICIQ-UI-SF) and higher patient age, were associated with statistically significant higher sum scores of the 12-month ICIQ-UI-SF, thus, representing higher impact of urinary incontinence (<xref ref-type="fig" rid="F1">Figure 1</xref>) (<xref ref-type="bibr" rid="B44">44</xref>). Together with the preoperative model a new, postoperative nomogram was introduced to inform patients about the probability of an additional surgery for incontinence or, on the other hand, about the importance of enduring with a strict pelvic floor muscle training protocol (<xref ref-type="fig" rid="F2">Figure 2</xref>) (<xref ref-type="bibr" rid="B44">44</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Nomogram for the preoperative prediction of the 12-month ICIQ-UI-SF score among patients diagnosed with prostate cancer and treated with robotic-assisted prostatectomy. Instructions: locate the patient&#x00027;s values for age, EAU risk classification, baseline EORCT QLQ-C30/QoL and baseline ICIQ-UI-SF on the corresponding axes. Draw a straight line up to the Points axis for each value to determine the number of points for that value. Calculate the sum of the values on the Points axis and locate this sum score on the Total Points axis. Draw a straight line down to find the patient&#x00027;s predicted ICIQ-UI-SF score at 12 months. From Tutolo et al. (<xref ref-type="bibr" rid="B44">44</xref>). EORCT QLQ-C30/QoL, European Organization for Research and Treatment for Cancer Quality of Life Questionnaire of Prostate Cancer; ICIQ-UI-SF, International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form; EAU, European Association of Urology.</p></caption>
<graphic xlink:href="fsurg-08-647656-g0001.tif"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Nomogram for the postoperative prediction of the 12-month ICIQ-UI-SF score among patients diagnosed with prostate cancer and treated with robotic-assisted laparoscopic prostatectomy. Instructions: locate the patient&#x00027;s values for age, 3-month EORCT QLQ-C30/QoL, intraoperative complications, preoperative ICIQ-UI-SF and 3-month ICIQ-UI-SF on the corresponding axes. Draw a straight line up to the Points axis for each value to determine the number of points for that value. Calculate the sum of the values on the Points axis and locate this sum score on the Total Points axis. Draw a straight line down to find the patient&#x00027;s predicted ICIQ-UI-SF score at 12 months. Taken From Tutolo et al. (<xref ref-type="bibr" rid="B44">44</xref>). EORCT QLQ-C30/QoL, European Organization for Research and Treatment for Cancer Quality of Life Questionnaire of Prostate Cancer; ICIQ-UI-SF, International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form.</p></caption>
<graphic xlink:href="fsurg-08-647656-g0002.tif"/>
</fig>
<p>Interestingly, these results did not show any association with ICIQ-UI-SF, when including surgery volume (namely &#x0003C;50, 50&#x02013;100, or &#x0003E;100 cases per year) (<xref ref-type="bibr" rid="B44">44</xref>).</p>
<p>R-squared (<italic>R</italic><sup>2</sup>), the statistical measure that represents the proportion of the variance for a dependent variable, equalled 4% and 43% in the preoperative and postoperative models, respectively. This is mainly due to the retrospective nature of the study and to the intrinsic characteristics of the database (strict rules of the Belgian Cancer registry). The major drawback of this study, together with its retrospective nature, is that a single dataset has been used for development and validation of the model. Although a non-random splitting of the data is an acceptable design for evaluating model performance, external validation still has to be performed (<xref ref-type="bibr" rid="B42">42</xref>).</p></sec>
<sec id="s5">
<title>Treatment of Male Stress Urinary Incontinence</title>
<sec>
<title>Conservative and Pharmacologic Therapy</title>
<p>Although there is conflicting evidence regarding the importance of conservative treatment after post-prostatectomy urinary incontinence (<xref ref-type="bibr" rid="B45">45</xref>), pelvic floor muscle training (PFMT) is still considered as the first treatment choice (<xref ref-type="bibr" rid="B46">46</xref>). Duloxetin, a serotonin/norepinephrine reuptake inhibitor, either alone or in combination with PFMT, may hasten recovery of urinary incontinence but is often associated with severe gastrointestinal and central nervous side effects (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>). However, neither PFMT nor duloxetine may cure male stress urinary incontinence.</p></sec>
<sec>
<title>Surgical Therapy</title>
<p>If conservative therapy fails, surgical treatment options should be offered to the patients. The artificial urinary sphincter (AUS) has been considered the gold standard for several decades. In a recent study urinary incontinence rates remained high, with no evidence of difference between male sling and AUS (<xref ref-type="bibr" rid="B49">49</xref>). The mode of function of AUS is a circumferential compression of the urethra based on a hydraulic mechanism. Nowadays, several alternative procedures with different operating principles compete against the AUS. These procedures are classified to bulking agents, male slings, and compressive devices. <xref ref-type="table" rid="T2">Table 2</xref> presents success and complications rates of different treatment options of selected clinical trials and <xref ref-type="fig" rid="F2">Figure 2</xref> demonstrates the different surgical devices <italic>in situ</italic>. <xref ref-type="table" rid="T2">Table 2</xref> presents success and complications rates of different treatment options of selected clinical trials and <xref ref-type="fig" rid="F2">Figure 2</xref> demonstrates the different surgical devices <italic>in situ</italic>.</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Continence and complications rates after different treatment modalities of male stress urinary incontinence in selected clinical trials.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>References</bold></th>
<th valign="top" align="left"><bold>Device</bold></th>
<th valign="top" align="left"><bold>Device type</bold></th>
<th valign="top" align="left"><bold>Year</bold></th>
<th valign="top" align="left"><bold>Study design</bold></th>
<th valign="top" align="center"><bold>Number of patients</bold></th>
<th valign="top" align="left"><bold>Follow-up time</bold></th>
<th valign="top" align="left"><bold>Continence definition</bold></th>
<th valign="top" align="left"><bold>Urinary continence, n/N (%)</bold></th>
<th valign="top" align="left"><bold>Complications</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Bauer et al. (<xref ref-type="bibr" rid="B50">50</xref>)</td>
<td valign="top" align="left">AdVanceXP</td>
<td valign="top" align="left">Fixed sling</td>
<td valign="top" align="left">2015</td>
<td valign="top" align="left">Prospective non-randomized</td>
<td valign="top" align="center">94</td>
<td valign="top" align="left">24 months</td>
<td valign="top" align="left">0 pads and 0&#x02013;5 g in 24 h pad test</td>
<td valign="top" align="left">35/46 (73.1)</td>
<td valign="top" align="left">Urinary tract infection <italic>n</italic> = 1, wound infection <italic>n</italic> = 2, urgency <italic>n</italic> = 3, explantation due to pain <italic>n</italic> = 2 or ineffectiveness <italic>n</italic> = 3</td>
</tr>
<tr>
<td valign="top" align="left">Collado Serra et al. (<xref ref-type="bibr" rid="B51">51</xref>)</td>
<td valign="top" align="left">AdVance AdVanceXP</td>
<td valign="top" align="left">Fixed sling</td>
<td valign="top" align="left">2013</td>
<td valign="top" align="left">Prospective non-randomized</td>
<td valign="top" align="center">61</td>
<td valign="top" align="left">26 months</td>
<td valign="top" align="left">0 pads/24h</td>
<td valign="top" align="left">49/61 (80.0)</td>
<td valign="top" align="left">Acute urinary retention <italic>n</italic> = 9(15%), perineal scrotal pain <italic>n</italic> = 5(8%), perineal hematoma <italic>n</italic> = 2(3%), <italic>deNovo</italic> urgency <italic>n</italic> = 5(8%)</td>
</tr>
<tr>
<td valign="top" align="left">Friedl et al. (<xref ref-type="bibr" rid="B52">52</xref>)</td>
<td valign="top" align="left">ATOMS</td>
<td valign="top" align="left">Adjustable sling</td>
<td valign="top" align="left">2017</td>
<td valign="top" align="left">Retrospective<break/> non-randomized</td>
<td valign="top" align="center">287</td>
<td valign="top" align="left">31 months</td>
<td valign="top" align="left">0&#x02013;1 pad/24 h, &#x0003C;10 ml/day</td>
<td valign="top" align="left">184/287 (64.0)</td>
<td valign="top" align="left">Urinary retention <italic>n</italic> = 8(3%), early infection <italic>n</italic> = 6 (2%), hematoma <italic>n</italic> = 6(2%), removals <italic>n</italic> = 56 (20%) due to titanium intolerance <italic>n</italic> = 23 (41%), leak <italic>n</italic> = 12(21%), early infection <italic>n</italic> = 6 (11%) late infection <italic>n</italic> = 6(11%), dysfunction <italic>n</italic> = 5(9%), dislocation <italic>n</italic> = 3(5%), persistent pain <italic>n</italic> = 1(2%) reimplantation <italic>n</italic> = 29 (52%), solitary port change <italic>n</italic> = 14(5%), AUS solution <italic>n</italic> = 11 (4%)</td>
</tr>
<tr>
<td valign="top" align="left">M&#x000FC;hlst&#x000E4;dt et al. (<xref ref-type="bibr" rid="B53">53</xref>)</td>
<td valign="top" align="left">ATOMS</td>
<td valign="top" align="left">Adjustable sling</td>
<td valign="top" align="left">2016</td>
<td valign="top" align="left">Retrospective<break/> nonrandomised</td>
<td valign="top" align="center">54</td>
<td valign="top" align="left">27.5 months</td>
<td valign="top" align="left">0&#x02013;1 pad/24 h</td>
<td valign="top" align="left">26/54 (48.1)</td>
<td valign="top" align="left">Scrotal hematoma <italic>n</italic> = 2 (3.7%), pain <italic>n</italic> = 3 (5.6%), urinary retention <italic>n</italic> = 1 (1.9%), woundinfection perineal <italic>n</italic> = 2 (3.7%), wound infection port- <italic>n</italic> = 4 (7.4%), port erosion <italic>n</italic> = 1 (1.9%), incipient erosion of the port <italic>n</italic> = 2 (3.7%)</td>
</tr>
<tr>
<td valign="top" align="left">Cornel et al. (<xref ref-type="bibr" rid="B54">54</xref>)</td>
<td valign="top" align="left">Argus</td>
<td valign="top" align="left">Adjustable sling</td>
<td valign="top" align="left">2016</td>
<td valign="top" align="left">Prospective non-randomized</td>
<td valign="top" align="center">36</td>
<td valign="top" align="left">12 months</td>
<td valign="top" align="left">0&#x02013;1 pad/24 h 0&#x02013;2 g/24 h</td>
<td valign="top" align="left">29/36 (82.9)</td>
<td valign="top" align="left">Urinary retention <italic>n</italic> = 7, Hematoma <italic>n</italic> = 1, insensibility scrotum <italic>n</italic> = 4, perineal pain &#x0003C;6 months <italic>n</italic> = 9, urinary tract infection <italic>n</italic> = 1, wound infection <italic>n</italic> = 6, inguinal wound reclosure removal sling column <italic>n</italic> = 3, sling infection and removal <italic>n</italic> = 3</td>
</tr>
<tr>
<td valign="top" align="left">Lima et al. (<xref ref-type="bibr" rid="B55">55</xref>)</td>
<td valign="top" align="left">Argus <break/> AdVance</td>
<td valign="top" align="left">Adjustable sling <break/> Fixed sling</td>
<td valign="top" align="left">2016</td>
<td valign="top" align="left">Prospective non-randomized</td>
<td valign="top" align="center">44</td>
<td valign="top" align="left">36.2 months <break/> 33.1 months</td>
<td valign="top" align="left">0&#x02013;1 pad/24 h</td>
<td valign="top" align="left">23/25 (92) <break/> 16/19 (84)</td>
<td valign="top" align="left">Argus: <italic>n</italic> = 1 (4%) urinary retention, Revision surgery for incontinence <italic>n</italic> = 6 (24%)<break/> AdVance: <italic>n</italic> = 2 (11%)urinary retention</td>
</tr>
<tr>
<td valign="top" align="left">Leizour et al. (<xref ref-type="bibr" rid="B56">56</xref>)</td>
<td valign="top" align="left">Remeex</td>
<td valign="top" align="left">Adjustable sling</td>
<td valign="top" align="left">2017</td>
<td valign="top" align="left">Prospective non-randomized</td>
<td valign="top" align="center">25</td>
<td valign="top" align="left">31 months</td>
<td valign="top" align="left">0 pad/24 h</td>
<td valign="top" align="left">9/25 (<xref ref-type="bibr" rid="B41">41</xref>)</td>
<td valign="top" align="left">Explantation <italic>n</italic> = 1, infection <italic>n</italic> = 3.</td>
</tr>
<tr>
<td valign="top" align="left">Rocha et al. (<xref ref-type="bibr" rid="B57">57</xref>)</td>
<td valign="top" align="left">AMS800</td>
<td valign="top" align="left">Artificial urinary sphincter</td>
<td valign="top" align="left">2008</td>
<td valign="top" align="left">Prospective non-randomized</td>
<td valign="top" align="center">40</td>
<td valign="top" align="left">53 months</td>
<td valign="top" align="left">0 pad/24 h</td>
<td valign="top" align="left">20/40 (50.0)</td>
<td valign="top" align="left">Perineal hematoma <italic>n</italic> = 1, device infection <italic>n</italic> = 3 (7.5%), mechanical failure <italic>n</italic> = 2(5%), urethral atrophy <italic>n</italic> = 2(5%), overactive bladder syndrome <italic>n</italic> = 4 (10%)</td>
</tr>
<tr>
<td valign="top" align="left">Kaiho et al. (<xref ref-type="bibr" rid="B58">58</xref>)</td>
<td valign="top" align="left">AMS800</td>
<td valign="top" align="left">Artificial urinary sphincter</td>
<td valign="top" align="left">2018</td>
<td valign="top" align="left">Prospective non-randomized</td>
<td valign="top" align="center">135</td>
<td valign="top" align="left">12 months</td>
<td valign="top" align="left">0 pads</td>
<td valign="top" align="left">27/93 (37.3)</td>
<td valign="top" align="left">Wound infection <italic>n</italic> = 5, urinary retention <italic>n</italic> = 4 hematoma <italic>n</italic> = 2, others <italic>n</italic> = 2, mechanical failure <italic>n</italic> = 7, late infection <italic>n</italic> = 4, urethral erosion <italic>n</italic> = 3, urethral erosion and infection <italic>n</italic> = 1, pump malposition <italic>n</italic> = 1,</td>
</tr>
<tr>
<td valign="top" align="left">Yiou et al. (<xref ref-type="bibr" rid="B59">59</xref>)</td>
<td valign="top" align="left">ProAct</td>
<td valign="top" align="left">Non-circumferential compressive</td>
<td valign="top" align="left">2015</td>
<td valign="top" align="left">Prospective non-randomized</td>
<td valign="top" align="center">20</td>
<td valign="top" align="left">12 months</td>
<td valign="top" align="left">0 pads</td>
<td valign="top" align="left">12/18 (66.7)</td>
<td valign="top" align="left">Late infection of perineal wound <italic>n</italic> = 2 due to additional InVance implantation</td>
</tr>
<tr>
<td valign="top" align="left">Crivellaro et al. (<xref ref-type="bibr" rid="B60">60</xref>)</td>
<td valign="top" align="left">ProAct</td>
<td valign="top" align="left">Non-circumferential compressive</td>
<td valign="top" align="left">2008</td>
<td valign="top" align="left">Prospective non-randomized</td>
<td valign="top" align="center">46</td>
<td valign="top" align="left">19 months</td>
<td valign="top" align="left">0&#x02013;1 pad/24 h</td>
<td valign="top" align="left">30/44 (68.0)</td>
<td valign="top" align="left">Erosion <italic>n</italic> = 2, spontaneous deflation <italic>n</italic> = 1, infection <italic>n</italic> = 1, migration <italic>n</italic> = 2, explantation <italic>n</italic> = 6</td>
</tr>
</tbody>
</table>
</table-wrap></sec>
<sec>
<title>Bulking Agents</title>
<p>Theoretically, bulking agents may be an attractive treatment option for patients with limited amount of urine loss, unfit for surgery, or unwilling for surgery with implantable devices (<xref ref-type="bibr" rid="B61">61</xref>). However, bulking agents have been discredited due to various complications, such as embolization, migration, absorptions, allergic, and fibrotic reactions. Novel bulking agents are characterized by their non-migrating and non-absorbable properties (<xref ref-type="bibr" rid="B62">62</xref>). Although bulking agents are commonly used in female SUI, evidence regarding the treatment of male SUI is scarce. Moreover, there is no standardized surgical technique regarding amount and position of injection. In a recent systematic review of bulking agents utilized for male SUI including polydimethylsiloxane elastomer (Macroplastique), polyacrylate polyalcohol copolymer (Opsys), carbon coated zirconium (Durasphere), and vinyl dimethyl terminated poly-dimethylsiloxane polymer (Urolastic), no final conclusion could be drawn due to the high risk of bias, incoherent reporting of urinary incontinence and surgical technique and contradictory results (<xref ref-type="bibr" rid="B61">61</xref>). It can be concluded that, there is currently, no recommendation for the utilization of bulking agents for the treatment of male stress urinary incontinence outside of clinical trials (<xref ref-type="bibr" rid="B46">46</xref>).</p></sec>
<sec>
<title>Male Slings</title>
<p>Male slings are minimally invasive procedures where a sling is positioned under the bulbar urethra through a retropubic or transobturator approach (<xref ref-type="bibr" rid="B46">46</xref>). They are distinguished into fixed and adjustable slings.</p></sec>
<sec>
<title>Fixed Slings</title>
<p>The mode of function of fixed slings is the reposition of the urethra to a proximal position without affecting the sphincter mechanism directly. This mechanism bases on the hypothesis, that urinary incontinence with residual sphincter function is caused by a urethral or perineal descent which is associated with lacity, iatrogenic causes, or aging in the levator ani complex (<xref ref-type="bibr" rid="B63">63</xref>). The distal urethral sphincter may be supported indirectly by a hammock underneath the urethral bulb though increasing the coaptative zone within the sphincteric membranous urethra. During increased physical exercise the blood flow is accumulated within the supported corpus spongiosum and hereby increases the zone of coaptation which is enabled by the male sling (<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>However, the current considerations base on the existence of an at least partial or complete presence of the urethral sphincter. Therefore, fixed slings are indicated in patients with mild to moderate male SUI (<xref ref-type="bibr" rid="B46">46</xref>) whereas, higher degrees of urinary incontinence should be reserved to compressive devices.</p>
<p>The most investigated fixed male sling is the AdVance, and second generation AdVanceXP (Boston Scientific, Marlborough, Massachusetts, USA). In mid-term follow up of the AdVanceXP in a selected patient population, 68.8% and 22.8% of the patients were either cured or improved, respectively, with a mean urine loss decreased to 19.1 g. Importantly, no intraoperative or long-term complications occurred in either of these patients (<xref ref-type="bibr" rid="B64">64</xref>). In a recent meta-analysis, the objective cure rates for fixed slings were reported between 8.3 and 87%. Pain was the most common complication although chronic pain was only reported in 1.3%. The second most common complication is urinary retention but being mostly a temporary condition (<xref ref-type="bibr" rid="B65">65</xref>).</p></sec>
<sec>
<title>Adjustable Slings</title>
<p>Adjustable slings offer the possibility of adjuvant adaptation of the sling tension or compression of the urethra by either tighten the sling arms or filling a cushion, which is localized beneath the urethra. The mode of function of adjustable slings are therefore complemented by the possibility of mechanical compression of the urethra (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Surgical devices for the treatment of male stress urinary incontinence. <bold>(a)</bold> Circumferential compressive three-piece artificial urinary sphincter AMS800 (Boston scientific, USA). <bold>(b)</bold> Non-circumferential compressive device ProACT (UroMedica, USA). <bold>(c)</bold> Fixed male sling AdVanceXP (Boston Scientific, USA). <bold>(d)</bold> Adjustable male sling ATOMS (A.M.I., Austria). <bold>(e)</bold> Adjustable male sling Argus (Promedon, Argentina). <bold>(f)</bold> Adjustable male sling Remeex (Neomedic, Spain).</p></caption>
<graphic xlink:href="fsurg-08-647656-g0003.tif"/>
</fig>
<p>Currently, there are three commercialized adjustable sling available: Remeex (Neomedic, Madrid, Spain), Argus (Promedon, Cordoba, Argentina), and ATOMS (A.M.I., Feldkirch, Austria). The currently most investigated adjustable sling is the ATOMS. In a recent meta-analysis including a total of 1.393 patients with an ATOMS, the mean cure rate was 67% and improvement of urinary SUI was 90%. The complication rate was 16.5% although major complications occurred in only 3% (<xref ref-type="bibr" rid="B66">66</xref>). Including all adjustable slings, the cure rate is reported between 17 and 92% in a meta-analysis. Chronic painful condition was 1.5% and the most common complication is infection with subsequent explantation of the device (<xref ref-type="bibr" rid="B65">65</xref>). These results are accordance with a large cohort trial, reporting a significant higher infection rate of 2.3% and pain rate of 11.9%. The total explantation rate was 4.0% (<xref ref-type="bibr" rid="B67">67</xref>). Furthermore, it could be demonstrated that adjustable slings are more commonly utilized in patients with higher degree of SUI and risk factors, although functional outcomes remained comparable to fixed slings.</p>
<p>In conclusion, there might be beneficial cure rates in adjustable slings in comparison to fixed slings. However, complications rates might be higher in adjustable slings.</p></sec>
<sec>
<title>Compressive Devices</title>
<p>Compressive devices can be distinguished between circumferential and non-circumferential devices.</p></sec>
<sec>
<title>Circumferential Compressive Devices</title>
<p>The AUS is a three-piece device including an urethral cuff, pump, and reservoir. The mode of function is a mechanical circumferential compression of the urethra and is based on a hydraulic mechanism. The most investigated device is the AMS800 (Boston Scientific, Marlborough, Massachusetts, USA). Its predecessor has been introduced in 1972 (<xref ref-type="bibr" rid="B68">68</xref>) and is available in the current shape since 1982 (<xref ref-type="bibr" rid="B69">69</xref>). The continence rate of the AUS are reported between 61 and 100% (<xref ref-type="bibr" rid="B70">70</xref>) and in a long-term analysis with a mean of 15 years, the continence rate was still 77.2%. Including any degree of urinary incontinence independently of the existence of the urethral sphincter. Therefore, the AUS is recommended for the treatment of moderate to severe male SUI and in particular in patients with a history of pelvic irradiation or urethral stricture disease.</p>
<p>Despite the favorable functional outcome, the AUS is associated with higher complications rates than male slings (<xref ref-type="bibr" rid="B71">71</xref>). The mean rate of infection and erosion in a pooled analysis was 8.5%, mechanical failure 6.2%, urethral atrophy 7.9%, and the mean rate of reintervention was 26%. Nevertheless, in particular patients with higher degree of urinary incontinence facing limited treatment options. If the AUS fails, the ultima ratio is urinary diversion.</p>
<p>Apart from the AMS800, which offer the largest amount of literature and follow-up time, there are several other commercialized AUS available. Victo (Promedon, Cordoba, Argentina) is three-piece device similar to the AMS800 but offers additional the possibility to adjust the device by increasing the intraluminal pressure through percutaneous fluid injection into a port which is located in the bottom of the pump. Zephyr (Zephyr Surgical Implants, Geneva, Switzerland) offers a two-piece device including only a pump and an urethral cuff. Furthermore, the device also offers the possibility of postoperative adjustability in a similar approach as described.</p></sec>
<sec>
<title>Non-circumferential Compressive Devices</title>
<p>ProAct (Uromedica, Plymouth, USA) is a non-circumferential compressive device. The mechanism is based on two balloons which are positioned lateral to the proximal urethra. The balloons are filled in an ambulatory matter and results in a mechanical compression of the urethra. The success rates are reported between 62 and 68% accompanied by explantation rate of 12.3%. The most common complications are erosion (3.2&#x02013;10.9 %) and dislocation (4&#x02013;6.2 %) (<xref ref-type="bibr" rid="B72">72</xref>). Other prospective series even reported complication rates between 11 and 58% (<xref ref-type="bibr" rid="B46">46</xref>). There is currently no direct recommendation for the utilization of ProAct in mal SUI in the European guidelines. However, in the summary of very limited evidence, it is evaluated as effective in short term, although associated with a high risk of complications and should not be offered to patients with a history of pelvic irradiation (<xref ref-type="bibr" rid="B46">46</xref>).</p></sec></sec>
<sec id="s6">
<title>Future Perspectives and Conclusions</title>
<p>Prostate cancer is one of the most problematic and frequently encountered malignancies in male patients. It often occurs when men are still in the active period of their lives. Consequently, there is a high demand for minimally invasive therapeutic approaches, susceptible of preserving urinary continence and sexual function. Unfortunately, stress urinary incontinence is a common adverse event in men with localized or locally advanced prostate cancer undergoing radical prostatectomy, but also secondary to radiotherapy (external beam radiotherapy as well as brachytherapy) and to cryosurgery (<xref ref-type="bibr" rid="B73">73</xref>).</p>
<p>Despite rehabilitative procedures such as pelvic floor muscle training, biofeedback, electrical stimulation, lifestyle changes, or a combination of these strategies, no fully efficient treatment alternative has yet been established for this pathology (<xref ref-type="bibr" rid="B74">74</xref>). On the other hand, it should be acknowledged that nursing care, including the understanding of the patient&#x00027;s needs, education, and psychosocial support remain essential features while aiming to improve the quality of life of prostate cancer patients.</p>
<p>Concerning the newest experimental treatments made available for urinary incontinence subsequent to prostate cancer surgery, there are studies that have shown a significant improvement of continence after ultrasound guided injection of fibroblasts and myoblasts into the sphincter (<xref ref-type="bibr" rid="B75">75</xref>). Other clinical trials also emphasized encouraging outcomes provided by stem-cells injection into the rhabdosphincter (<xref ref-type="bibr" rid="B76">76</xref>). Last but not least, promising outcomes have been outlined as a result of intravesical Onabotulinum toxin A injection (<xref ref-type="bibr" rid="B77">77</xref>).</p>
<p>Most importantly, the therapeutic decision and the chosen treatment option must be individualized for each patient according to clinical and social factors. During the recent years, the development of new therapeutic choices such as male sling techniques provided a more acceptable management pathway for less severe forms of urinary incontinence related to radical prostatectomy. Following this perspective, technological improvements and the emergence of new dedicated devices currently create the premises for a continuously positive evolution of clinical outcomes in this particular category of patients.</p></sec>
<sec id="s7">
<title>Author Contributions</title>
<p>MR: data collection, coordination and drafting the manuscript, and supervising. TM and TH: data collection, drafting the manuscript, and supervising. BG and MT: data collection and drafting the manuscript.</p></sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferlay</surname> <given-names>J</given-names></name> <name><surname>Colombet</surname> <given-names>M</given-names></name> <name><surname>Soerjomataram</surname> <given-names>I</given-names></name> <name><surname>Dyba</surname> <given-names>T</given-names></name> <name><surname>Randi</surname> <given-names>G</given-names></name> <name><surname>Bettio</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018</article-title>. <source>Eur J Cancer.</source> (<year>2018</year>) <volume>103</volume>:<fpage>356</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejca.2018.07.005</pub-id><pub-id pub-id-type="pmid">30100160</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>EAU-EANM-ESTRO-ESUR-SIOG</collab></person-group>. <article-title>Guidelines on prostate cancer 2020v4 2020</article-title>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://uroweb.org/wp-content/uploads/EAU-EANM-ESTRO-ESUR-SIOG-Guidelines-on-Prostate-Cancer-2020v4.pdf">https://uroweb.org/wp-content/uploads/EAU-EANM-ESTRO-ESUR-SIOG-Guidelines-on-Prostate-Cancer-2020v4.pdf</ext-link>.</citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kretschmer</surname> <given-names>A</given-names></name> <name><surname>Nitti</surname> <given-names>V</given-names></name></person-group>. <article-title>Surgical treatment of male postprostatectomy incontinence: current concepts</article-title>. <source>Eur Urol Focus.</source> (<year>2017</year>) <volume>3</volume>:<fpage>364</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.euf.2017.11.007</pub-id><pub-id pub-id-type="pmid">29174616</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abrams</surname> <given-names>P</given-names></name> <name><surname>Cardozo</surname> <given-names>L</given-names></name> <name><surname>Fall</surname> <given-names>M</given-names></name> <name><surname>Griffiths</surname> <given-names>D</given-names></name> <name><surname>Rosier</surname> <given-names>P</given-names></name> <name><surname>Ulmsten</surname> <given-names>U</given-names></name> <etal/></person-group>. <article-title>The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society</article-title>. <source>Neurourol Urodyn.</source> (<year>2002</year>) <volume>21</volume>:<fpage>167</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1002/nau.10052</pub-id><pub-id pub-id-type="pmid">12559262</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>D&#x00027;Ancona</surname> <given-names>C</given-names></name> <name><surname>Haylen</surname> <given-names>B</given-names></name> <name><surname>Oelke</surname> <given-names>M</given-names></name> <name><surname>Abranches-Monteiro</surname> <given-names>L</given-names></name> <name><surname>Arnold</surname> <given-names>E</given-names></name> <name><surname>Goldman</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>The international continence society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction</article-title>. <source>Neurourol Urodyn</source>. (<year>2019</year>) <volume>38</volume>:<fpage>433</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1002/nau.23897</pub-id><pub-id pub-id-type="pmid">31219383</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>John</surname> <given-names>H</given-names></name> <name><surname>Sullivan</surname> <given-names>MP</given-names></name> <name><surname>Bangerter</surname> <given-names>U</given-names></name> <name><surname>Hauri</surname> <given-names>D</given-names></name> <name><surname>Yalla</surname> <given-names>SV</given-names></name></person-group>. <article-title>Effect of radical prostatectomy on sensory threshold and pressure transmission</article-title>. <source>J Urol</source>. (<year>2000</year>) <volume>163</volume>:<fpage>1761</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5347(05)67537-4</pub-id><pub-id pub-id-type="pmid">10799177</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rehder</surname> <given-names>P</given-names></name> <name><surname>Staudacher</surname> <given-names>NM</given-names></name> <name><surname>Schachtner</surname> <given-names>J</given-names></name> <name><surname>Berger</surname> <given-names>ME</given-names></name> <name><surname>Schillfahrt</surname> <given-names>F</given-names></name> <name><surname>Hauser</surname> <given-names>V</given-names></name> <etal/></person-group>. <article-title>Hypothesis that urethral bulb (Corpus Spongiosum) plays an active role in male urinary continence</article-title>. <source>Adv Urol.</source> (<year>2016</year>) <volume>2016</volume>:<fpage>6054730</fpage>. <pub-id pub-id-type="doi">10.1155/2016/6054730</pub-id><pub-id pub-id-type="pmid">27022393</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sallami</surname> <given-names>S</given-names></name></person-group>. <article-title>Predictive factors of urinary incontinence after radical prostatectomy: systematic review</article-title>. <source>Tunis Med.</source> (<year>2017</year>) <volume>95</volume>:<fpage>229</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">29492925</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>R</given-names></name> <name><surname>Te</surname> <given-names>AE</given-names></name> <name><surname>Kaplan</surname> <given-names>SA</given-names></name> <name><surname>Sandhu</surname> <given-names>JS</given-names></name></person-group>. <article-title>Temporal trends in adoption of and indications for the artificial urinary sphincter</article-title>. <source>J Urol.</source> (<year>2009</year>) <volume>181</volume>:<fpage>2622</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.juro.2009.01.113</pub-id><pub-id pub-id-type="pmid">19375102</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haglind</surname> <given-names>E</given-names></name> <name><surname>Carlsson</surname> <given-names>S</given-names></name> <name><surname>Stranne</surname> <given-names>J</given-names></name> <name><surname>Wallerstedt</surname> <given-names>A</given-names></name> <name><surname>Wilderang</surname> <given-names>U</given-names></name> <name><surname>Thorsteinsdottir</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled, nonrandomised trial</article-title>. <source>Eur Urol</source>. (<year>2015</year>) <volume>68</volume>:<fpage>216</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2015.02.029</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>K</given-names></name> <name><surname>Jiang</surname> <given-names>K</given-names></name> <name><surname>Chen</surname> <given-names>H</given-names></name> <name><surname>Chen</surname> <given-names>Z</given-names></name> <name><surname>Xu</surname> <given-names>H</given-names></name> <name><surname>Ye</surname> <given-names>Z</given-names></name></person-group>. <article-title>Robotic vs. Retropubic radical prostatectomy in prostate cancer: a systematic review and an meta-analysis update</article-title>. <source>Oncotarget</source>. (<year>2017</year>) <volume>8</volume>:<fpage>32237</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.13332</pub-id><pub-id pub-id-type="pmid">27852051</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coughlin</surname> <given-names>GD</given-names></name> <name><surname>Yaxley</surname> <given-names>JW</given-names></name> <name><surname>Chambers</surname> <given-names>SK</given-names></name> <name><surname>Occhipinti</surname> <given-names>S</given-names></name> <name><surname>Samaratunga</surname> <given-names>H</given-names></name> <name><surname>Zajdlewicz</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study</article-title>. <source>Lancet Oncol.</source> (<year>2018</year>) <volume>19</volume>:<fpage>1051</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/S1470-2045(18)30357-7</pub-id><pub-id pub-id-type="pmid">30391081</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Porpiglia</surname> <given-names>F</given-names></name> <name><surname>Morra</surname> <given-names>I</given-names></name> <name><surname>Lucci Chiarissi</surname> <given-names>M</given-names></name> <name><surname>Manfredi</surname> <given-names>M</given-names></name> <name><surname>Mele</surname> <given-names>F</given-names></name> <name><surname>Grande</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Randomised controlled trial comparing laparoscopic and robot-assisted radical prostatectomy</article-title>. <source>Eur Urol.</source> (<year>2013</year>) <volume>63</volume>:<fpage>606</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2012.07.007</pub-id><pub-id pub-id-type="pmid">28753822</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Basiri</surname> <given-names>A</given-names></name> <name><surname>de la Rosette</surname> <given-names>JJ</given-names></name> <name><surname>Tabatabaei</surname> <given-names>S</given-names></name> <name><surname>Woo</surname> <given-names>HH</given-names></name> <name><surname>Laguna</surname> <given-names>MP</given-names></name> <name><surname>Shemshaki</surname> <given-names>H</given-names></name></person-group>. <article-title>Comparison of retropubic, laparoscopic and robotic radical prostatectomy: who is the winner?</article-title> <source>World J Urol</source>. (<year>2018</year>) <volume>36</volume>:<fpage>609</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1007/s00345-018-2174-1</pub-id><pub-id pub-id-type="pmid">29362896</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choo</surname> <given-names>MS</given-names></name> <name><surname>Choi</surname> <given-names>WS</given-names></name> <name><surname>Cho</surname> <given-names>SY</given-names></name> <name><surname>Ku</surname> <given-names>JH</given-names></name> <name><surname>Kim</surname> <given-names>HH</given-names></name> <name><surname>Kwak</surname> <given-names>C</given-names></name></person-group>. <article-title>Impact of prostate volume on oncological and functional outcomes after radical prostatectomy: robot-assisted laparoscopic versus open retropubic</article-title>. <source>Korean J Urol.</source> (<year>2013</year>) <volume>54</volume>:<fpage>15</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.4111/kju.2013.54.1.15</pub-id><pub-id pub-id-type="pmid">23362442</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rocco</surname> <given-names>B</given-names></name> <name><surname>Matei</surname> <given-names>DV</given-names></name> <name><surname>Melegari</surname> <given-names>S</given-names></name> <name><surname>Ospina</surname> <given-names>JC</given-names></name> <name><surname>Mazzoleni</surname> <given-names>F</given-names></name> <name><surname>Errico</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Robotic vs open prostatectomy in a laparoscopically naive centre: a matched-pair analysis</article-title>. <source>BJU Int</source>. (<year>2009</year>) <volume>104</volume>:<fpage>991</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1111/j.1464-410X.2009.08532.x</pub-id><pub-id pub-id-type="pmid">19426191</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Son</surname> <given-names>SJ</given-names></name> <name><surname>Lee</surname> <given-names>SC</given-names></name> <name><surname>Jeong</surname> <given-names>CW</given-names></name> <name><surname>Jeong</surname> <given-names>SJ</given-names></name> <name><surname>Byun</surname> <given-names>SS</given-names></name> <name><surname>Lee</surname> <given-names>SE</given-names></name></person-group>. <article-title>Comparison of continence recovery between robot-assisted laparoscopic prostatectomy and open radical retropubic prostatectomy: a single surgeon experience</article-title>. <source>Korean J Urol</source>. (<year>2013</year>) <volume>54</volume>:<fpage>598</fpage>&#x02013;<lpage>602</lpage>. <pub-id pub-id-type="doi">10.4111/kju.2013.54.9.598</pub-id><pub-id pub-id-type="pmid">24044093</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>M</given-names></name> <name><surname>Park</surname> <given-names>M</given-names></name> <name><surname>Pak</surname> <given-names>S</given-names></name> <name><surname>Choi</surname> <given-names>SK</given-names></name> <name><surname>Shim</surname> <given-names>M</given-names></name> <name><surname>Song</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Integrity of the urethral sphincter complex, nerve-sparing, and long-term continence status after robotic-assisted radical prostatectomy</article-title>. <source>Eur Urol Focus.</source> (<year>2019</year>) <volume>5</volume>:<fpage>823</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.euf.2018.04.021</pub-id><pub-id pub-id-type="pmid">29759661</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olsson</surname> <given-names>LE</given-names></name> <name><surname>Salomon</surname> <given-names>L</given-names></name> <name><surname>Nadu</surname> <given-names>A</given-names></name> <name><surname>Hoznek</surname> <given-names>A</given-names></name> <name><surname>Cicco</surname> <given-names>A</given-names></name> <name><surname>Saint</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>Prospective patient-reported continence after laparoscopic radical prostatectomy</article-title>. <source>Urology</source>. (<year>2001</year>) <volume>58</volume>:<fpage>570</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1016/S0090-4295(01)01261-4</pub-id><pub-id pub-id-type="pmid">11597541</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sumarsono</surname> <given-names>B</given-names></name> <name><surname>Jong</surname> <given-names>JJ</given-names></name> <name><surname>Wang</surname> <given-names>JY</given-names></name> <name><surname>Liao</surname> <given-names>L</given-names></name> <name><surname>Lee</surname> <given-names>KS</given-names></name> <name><surname>Yoo</surname> <given-names>TK</given-names></name> <etal/></person-group>. <article-title>The prevalence of urinary incontinence in men and women aged 40 years or over in China, Taiwan and South Korea: a cross-sectional, prevalence-based study</article-title>. <source>Low Urin Tract Symptoms.</source> (<year>2020</year>) <volume>12</volume>:<fpage>223</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1111/luts.12308</pub-id><pub-id pub-id-type="pmid">32207219</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Averbeck</surname> <given-names>MA</given-names></name> <name><surname>Marcelissen</surname> <given-names>T</given-names></name> <name><surname>Anding</surname> <given-names>R</given-names></name> <name><surname>Rahnama&#x00027;i</surname> <given-names>MS</given-names></name> <name><surname>Sahai</surname> <given-names>A</given-names></name> <name><surname>Tubaro</surname> <given-names>A</given-names></name></person-group>. <article-title>How can we prevent postprostatectomy urinary incontinence by patient selection, and by preoperative, peroperative, and postoperative measures? International Consultation on Incontinence-Research Society 2018</article-title>. <source>Neurourol Urodyn.</source> (<year>2019</year>) <volume>38</volume>(<supplement>Suppl 5</supplement>):<fpage>S119</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1002/nau.23972</pub-id><pub-id pub-id-type="pmid">31821626</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heesakkers</surname> <given-names>J</given-names></name> <name><surname>Farag</surname> <given-names>F</given-names></name> <name><surname>Bauer</surname> <given-names>RM</given-names></name> <name><surname>Sandhu</surname> <given-names>J</given-names></name> <name><surname>De Ridder</surname> <given-names>D</given-names></name> <name><surname>Stenzl</surname> <given-names>A</given-names></name></person-group>. <article-title>Pathophysiology and contributing factors in postprostatectomy incontinence: a review</article-title>. <source>Eur Urol.</source> (<year>2017</year>) <volume>71</volume>:<fpage>936</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2016.09.031</pub-id><pub-id pub-id-type="pmid">27720536</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oelrich</surname> <given-names>TM</given-names></name></person-group>. <article-title>The urethral sphincter muscle in the male</article-title>. <source>Am J Anat.</source> (<year>1980</year>) <volume>158</volume>:<fpage>229</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1002/aja.1001580211</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname> <given-names>MS</given-names></name></person-group>. <article-title>The puboprostatic ligament and the male urethral suspensory mechanism: an anatomic study</article-title>. <source>Urology</source>. (<year>1994</year>) <volume>44</volume>:<fpage>530</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/S0090-4295(94)80052-9</pub-id><pub-id pub-id-type="pmid">7941191</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strasser</surname> <given-names>H</given-names></name> <name><surname>Frauscher</surname> <given-names>F</given-names></name> <name><surname>Helweg</surname> <given-names>G</given-names></name> <name><surname>Colleselli</surname> <given-names>K</given-names></name> <name><surname>Reissigl</surname> <given-names>A</given-names></name> <name><surname>Bartsch</surname> <given-names>G</given-names></name></person-group>. <article-title>Transurethral ultrasound: evaluation of anatomy and function of the rhabdosphincter of the male urethra</article-title>. <source>J Urol.</source> (<year>1998</year>) <volume>159</volume>:<fpage>100</fpage>&#x02013;<lpage>4</lpage>; discussion 4&#x02013;5. <pub-id pub-id-type="doi">10.1016/S0022-5347(01)64025-4</pub-id><pub-id pub-id-type="pmid">9400446</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gomha</surname> <given-names>MA</given-names></name> <name><surname>Boone</surname> <given-names>TB</given-names></name></person-group>. <article-title>Voiding patterns in patients with post-prostatectomy incontinence: urodynamic and demographic analysis</article-title>. <source>J Urol</source>. (<year>2003</year>) <volume>169</volume>:<fpage>1766</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/01.ju.0000059700.21764.83</pub-id><pub-id pub-id-type="pmid">12686829</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>John</surname> <given-names>H</given-names></name></person-group>. <article-title>Bulbourethral composite suspension: a new operative technique for post-prostatectomy incontinence</article-title>. <source>J Urol.</source> (<year>2004</year>) <volume>171</volume>:<fpage>1866</fpage>&#x02013;<lpage>70</lpage>; discussion 9&#x02013;70. <pub-id pub-id-type="doi">10.1097/01.ju.0000121413.62521.cc</pub-id></citation>
</ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Majoros</surname> <given-names>A</given-names></name> <name><surname>Bach</surname> <given-names>D</given-names></name> <name><surname>Keszthelyi</surname> <given-names>A</given-names></name> <name><surname>Hamvas</surname> <given-names>A</given-names></name> <name><surname>Romics</surname> <given-names>I</given-names></name></person-group>. <article-title>Urinary incontinence and voiding dysfunction after radical retropubic prostatectomy (prospective urodynamic study)</article-title>. <source>Neurourol Urodyn</source>. (<year>2006</year>) <volume>25</volume>:<fpage>2</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/nau.20190</pub-id></citation>
</ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsukawa</surname> <given-names>Y</given-names></name> <name><surname>Hattori</surname> <given-names>R</given-names></name> <name><surname>Komatsu</surname> <given-names>T</given-names></name> <name><surname>Funahashi</surname> <given-names>Y</given-names></name> <name><surname>Sassa</surname> <given-names>N</given-names></name> <name><surname>Gotoh</surname> <given-names>M</given-names></name></person-group>. <article-title><italic>De novo</italic> detrusor underactivity after laparoscopic radical prostatectomy</article-title>. <source>Int J Urol</source>. (<year>2010</year>) <volume>17</volume>:<fpage>643</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/j.1442-2042.2010.02529.x</pub-id><pub-id pub-id-type="pmid">20438594</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Porena</surname> <given-names>M</given-names></name> <name><surname>Mearini</surname> <given-names>E</given-names></name> <name><surname>Mearini</surname> <given-names>L</given-names></name> <name><surname>Vianello</surname> <given-names>A</given-names></name> <name><surname>Giannantoni</surname> <given-names>A</given-names></name></person-group>. <article-title>Voiding dysfunction after radical retropubic prostatectomy: more than external urethral sphincter deficiency</article-title>. <source>Eur Urol</source>. (<year>2007</year>) <volume>52</volume>:<fpage>38</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2007.03.051</pub-id><pub-id pub-id-type="pmid">17403565</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Groutz</surname> <given-names>A</given-names></name> <name><surname>Blaivas</surname> <given-names>JG</given-names></name> <name><surname>Chaikin</surname> <given-names>DC</given-names></name> <name><surname>Weiss</surname> <given-names>JP</given-names></name> <name><surname>Verhaaren</surname> <given-names>M</given-names></name></person-group>. <article-title>The pathophysiology of post-radical prostatectomy incontinence: a clinical and video urodynamic study</article-title>. <source>J Urol</source>. (<year>2000</year>) <volume>163</volume>:<fpage>1767</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5347(05)67538-6</pub-id><pub-id pub-id-type="pmid">10799178</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kielb</surname> <given-names>SJ</given-names></name> <name><surname>Clemens</surname> <given-names>JQ</given-names></name></person-group>. <article-title>Comprehensive urodynamics evaluation of 146 men with incontinence after radical prostatectomy</article-title>. <source>Urology</source>. (<year>2005</year>) <volume>66</volume>:<fpage>392</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.urology.2005.03.026</pub-id><pub-id pub-id-type="pmid">16040102</pub-id></citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trieu</surname> <given-names>D</given-names></name> <name><surname>Ju</surname> <given-names>IE</given-names></name> <name><surname>Chang</surname> <given-names>SB</given-names></name> <name><surname>Mungovan</surname> <given-names>SF</given-names></name> <name><surname>Patel</surname> <given-names>MI</given-names></name></person-group>. <article-title>Surgeon case volume and continence recovery following radical prostatectomy: a systematic review</article-title>. <source>ANZ J Surg.</source> (<year>2020</year>). <pub-id pub-id-type="doi">10.1111/ans.16491</pub-id><pub-id pub-id-type="pmid">33319438</pub-id></citation></ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peyronnet</surname> <given-names>B</given-names></name> <name><surname>Brucker</surname> <given-names>BM</given-names></name></person-group>. <article-title>Management of overactive bladder symptoms after radical prostatectomy</article-title>. <source>Curr Urol Rep.</source> (<year>2018</year>) <volume>19</volume>:<fpage>95</fpage>. <pub-id pub-id-type="doi">10.1007/s11934-018-0847-3</pub-id><pub-id pub-id-type="pmid">30306278</pub-id></citation></ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chapple</surname> <given-names>C</given-names></name></person-group>. <article-title>Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of &#x0201C;overactive bladder&#x0201D;</article-title>. <source>Neurourol Urodyn</source>. (<year>2014</year>) <volume>33</volume>(<supplement>Suppl 3</supplement>):<fpage>S6</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1002/nau.22635</pub-id><pub-id pub-id-type="pmid">25042142</pub-id></citation></ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname> <given-names>SY</given-names></name> <name><surname>Fraser</surname> <given-names>MO</given-names></name> <name><surname>Ozawa</surname> <given-names>H</given-names></name> <name><surname>Yokoyama</surname> <given-names>O</given-names></name> <name><surname>Yoshiyama</surname> <given-names>M</given-names></name> <name><surname>De Groat</surname> <given-names>WC</given-names></name> <etal/></person-group>. <article-title>Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability</article-title>. <source>J Urol</source>. (<year>1999</year>) <volume>162</volume>:<fpage>204</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1097/00005392-199907000-00069</pub-id><pub-id pub-id-type="pmid">10379788</pub-id></citation></ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shafik</surname> <given-names>A</given-names></name> <name><surname>Shafik</surname> <given-names>AA</given-names></name> <name><surname>El-Sibai</surname> <given-names>O</given-names></name> <name><surname>Ahmed</surname> <given-names>I</given-names></name></person-group>. <article-title>Role of positive urethrovesical feedback in vesical evacuation. The concept of a second micturition reflex: the urethrovesical reflex</article-title>. <source>World J Urol</source>. (<year>2003</year>) <volume>21</volume>:<fpage>167</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1007/s00345-003-0340-5</pub-id><pub-id pub-id-type="pmid">12898170</pub-id></citation></ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shafik</surname> <given-names>A</given-names></name> <name><surname>el-Sibai</surname> <given-names>O</given-names></name> <name><surname>Ahmed</surname> <given-names>I</given-names></name></person-group>. <article-title>Effect of urethral dilation on vesical motor activity: identification of the urethrovesical reflex and its role in voiding</article-title>. <source>J Urol</source>. (<year>2003</year>) <volume>169</volume>:<fpage>1017</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/01.ju.0000046384.71563.51</pub-id><pub-id pub-id-type="pmid">12576835</pub-id></citation></ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hubeaux</surname> <given-names>K</given-names></name> <name><surname>Deffieux</surname> <given-names>X</given-names></name> <name><surname>Desseaux</surname> <given-names>K</given-names></name> <name><surname>Verollet</surname> <given-names>D</given-names></name> <name><surname>Damphousse</surname> <given-names>M</given-names></name> <name><surname>Amarenco</surname> <given-names>G</given-names></name></person-group>. <article-title>Stand up urgency: is this symptom related to a urethral mechanism?</article-title> <source>Prog Urol</source>. (<year>2012</year>) <volume>22</volume>:<fpage>475</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.purol.2012.04.011</pub-id><pub-id pub-id-type="pmid">22732583</pub-id></citation></ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsukawa</surname> <given-names>Y</given-names></name> <name><surname>Yoshino</surname> <given-names>Y</given-names></name> <name><surname>Ishida</surname> <given-names>S</given-names></name> <name><surname>Fujita</surname> <given-names>T</given-names></name> <name><surname>Majima</surname> <given-names>T</given-names></name> <name><surname>Funahashi</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>De novo overactive bladder after robot-assisted laparoscopic radical prostatectomy</article-title>. <source>Neurourol Urodyn.</source> (<year>2018</year>) <volume>37</volume>:<fpage>2008</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1002/nau.23556</pub-id><pub-id pub-id-type="pmid">29635709</pub-id></citation></ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname> <given-names>DE</given-names></name> <name><surname>Dillon</surname> <given-names>B</given-names></name> <name><surname>Kurta</surname> <given-names>J</given-names></name> <name><surname>Maschino</surname> <given-names>A</given-names></name> <name><surname>Cronin</surname> <given-names>A</given-names></name> <name><surname>Sandhu</surname> <given-names>JS</given-names></name></person-group>. <article-title>Detrusor underactivity is prevalent after radical prostatectomy: a urodynamic study including risk factors</article-title>. <source>Can Urol Assoc J</source>. (<year>2013</year>) <volume>7</volume>:<fpage>E33</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.5489/cuaj.192</pub-id><pub-id pub-id-type="pmid">22277630</pub-id></citation></ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jarosek</surname> <given-names>SL</given-names></name> <name><surname>Virnig</surname> <given-names>BA</given-names></name> <name><surname>Chu</surname> <given-names>H</given-names></name> <name><surname>Elliott</surname> <given-names>SP</given-names></name></person-group>. <article-title>Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both</article-title>. <source>Eur Urol</source>. (<year>2015</year>) <volume>67</volume>:<fpage>273</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2014.08.061</pub-id><pub-id pub-id-type="pmid">25217421</pub-id></citation></ref>
<ref id="B43">
<label>43.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drake</surname> <given-names>MJ</given-names></name> <name><surname>Kanai</surname> <given-names>A</given-names></name> <name><surname>Bijos</surname> <given-names>DA</given-names></name> <name><surname>Ikeda</surname> <given-names>Y</given-names></name> <name><surname>Zabbarova</surname> <given-names>I</given-names></name> <name><surname>Vahabi</surname> <given-names>B</given-names></name> <etal/></person-group>. <article-title>The potential role of unregulated autonomous bladder micromotions in urinary storage and voiding dysfunction; overactive bladder and detrusor underactivity</article-title>. <source>BJU Int</source>. (<year>2017</year>) <volume>119</volume>:<fpage>22</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/bju.13598</pub-id><pub-id pub-id-type="pmid">28817923</pub-id></citation></ref>
<ref id="B44">
<label>44.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tutolo</surname> <given-names>M</given-names></name> <name><surname>Bruyneel</surname> <given-names>L</given-names></name> <name><surname>Van der Aa</surname> <given-names>F</given-names></name> <name><surname>Van Damme</surname> <given-names>N</given-names></name> <name><surname>Van Cleynenbreugel</surname> <given-names>B</given-names></name> <name><surname>Joniau</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>A novel tool to predict functional outcomes after robot-assisted radical prostatectomy and the value of additional surgery for incontinence</article-title>. <source>BJU Int</source>. (<year>2020</year>). <pub-id pub-id-type="doi">10.1111/bju.15242</pub-id><pub-id pub-id-type="pmid">32929874</pub-id>. [Epub ahead of print].</citation></ref>
<ref id="B45">
<label>45.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>CA</given-names></name> <name><surname>Omar</surname> <given-names>MI</given-names></name> <name><surname>Campbell</surname> <given-names>SE</given-names></name> <name><surname>Hunter</surname> <given-names>KF</given-names></name> <name><surname>Cody</surname> <given-names>JD</given-names></name> <name><surname>Glazener</surname> <given-names>CM</given-names></name></person-group>. <article-title>Conservative management for postprostatectomy urinary incontinence</article-title>. <source>Cochrane Database Syst Rev</source>. (<year>2015</year>) <volume>1</volume>:<fpage>CD001843</fpage>. <pub-id pub-id-type="doi">10.1002/14651858.CD001843.pub5</pub-id><pub-id pub-id-type="pmid">25602133</pub-id></citation></ref>
<ref id="B46">
<label>46.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burkhard</surname> <given-names>FC</given-names></name> <name><surname>Bosch</surname> <given-names>RJL</given-names></name> <name><surname>Cruz</surname> <given-names>F</given-names></name> <name><surname>Lemack</surname> <given-names>GE</given-names></name> <name><surname>Nambiar</surname> <given-names>AK</given-names></name> <name><surname>Thiruchelvam</surname> <given-names>N</given-names></name> <etal/></person-group>. <source>EAU Guidelines on Urinary Incontinence</source> (<year>2020</year>).</citation></ref>
<ref id="B47">
<label>47.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alan</surname> <given-names>C</given-names></name> <name><surname>Eren</surname> <given-names>AE</given-names></name> <name><surname>Ersay</surname> <given-names>AR</given-names></name> <name><surname>Kocoglu</surname> <given-names>H</given-names></name> <name><surname>Basturk</surname> <given-names>G</given-names></name> <name><surname>Demirci</surname> <given-names>E</given-names></name></person-group>. <article-title>Efficacy of duloxetine in the early management of urinary continence after radical prostatectomy</article-title>. <source>Curr Urol.</source> (<year>2015</year>) <volume>8</volume>:<fpage>43</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1159/000365688</pub-id><pub-id pub-id-type="pmid">26195963</pub-id></citation></ref>
<ref id="B48">
<label>48.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Filocamo</surname> <given-names>MT</given-names></name> <name><surname>Li Marzi</surname> <given-names>V</given-names></name> <name><surname>Del Popolo</surname> <given-names>G</given-names></name> <name><surname>Cecconi</surname> <given-names>F</given-names></name> <name><surname>Villari</surname> <given-names>D</given-names></name> <name><surname>Marzocco</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Pharmacologic treatment in postprostatectomy stress urinary incontinence</article-title>. <source>Eur Urol</source>. (<year>2007</year>) <volume>51</volume>:<fpage>1559</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2006.08.005</pub-id><pub-id pub-id-type="pmid">16942833</pub-id></citation></ref>
<ref id="B49">
<label>49.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abrams</surname> <given-names>P</given-names></name> <name><surname>Constable</surname> <given-names>LD</given-names></name> <name><surname>Cooper</surname> <given-names>D</given-names></name> <name><surname>MacLennan</surname> <given-names>G</given-names></name> <name><surname>Drake</surname> <given-names>MJ</given-names></name> <name><surname>Harding</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Outcomes of a noninferiority randomised controlled trial of surgery for men with urodynamic stress incontinence after prostate surgery (MASTER)</article-title>. <source>Eur Urol.</source> (<year>2021</year>). <pub-id pub-id-type="doi">10.1016/j.eururo.2021.01.024</pub-id><pub-id pub-id-type="pmid">33551297</pub-id>. [Epub ahead of print].</citation></ref>
<ref id="B50">
<label>50.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname> <given-names>RM</given-names></name> <name><surname>Gozzi</surname> <given-names>C</given-names></name> <name><surname>Klehr</surname> <given-names>B</given-names></name> <name><surname>Kretschmer</surname> <given-names>A</given-names></name> <name><surname>Grabbert</surname> <given-names>M</given-names></name> <name><surname>Rehder</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>AdVanceXP male sling: 2-year results of a multicentre study</article-title>. <source>World J Urol</source>. (<year>2015</year>) <volume>34</volume>:<fpage>1025</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1007/s00345-015-1731-0</pub-id><pub-id pub-id-type="pmid">26582060</pub-id></citation></ref>
<ref id="B51">
<label>51.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collado Serra</surname> <given-names>A</given-names></name> <name><surname>Resel Folkersma</surname> <given-names>L</given-names></name> <name><surname>Dominguez-Escrig</surname> <given-names>JL</given-names></name> <name><surname>Gomez-Ferrer</surname> <given-names>A</given-names></name> <name><surname>Rubio-Briones</surname> <given-names>J</given-names></name> <name><surname>Solsona Narbon</surname> <given-names>E</given-names></name></person-group>. <article-title>AdVance/AdVance XP transobturator male slings: preoperative degree of incontinence as predictor of surgical outcome</article-title>. <source>Urology</source>. (<year>2013</year>) <volume>81</volume>:<fpage>1034</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.urology.2013.01.007</pub-id><pub-id pub-id-type="pmid">24209540</pub-id></citation></ref>
<ref id="B52">
<label>52.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedl</surname> <given-names>A</given-names></name> <name><surname>Muhlstadt</surname> <given-names>S</given-names></name> <name><surname>Zachoval</surname> <given-names>R</given-names></name> <name><surname>Giammo</surname> <given-names>A</given-names></name> <name><surname>Kivaranovic</surname> <given-names>D</given-names></name> <name><surname>Rom</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Long-term outcome of the adjustable transobturator male system (ATOMS): results of a European multicentre study</article-title>. <source>BJU Int.</source> (<year>2017</year>) <volume>119</volume>:<fpage>785</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1111/bju.13684</pub-id><pub-id pub-id-type="pmid">27868328</pub-id></citation></ref>
<ref id="B53">
<label>53.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muhlstadt</surname> <given-names>S</given-names></name> <name><surname>Friedl</surname> <given-names>A</given-names></name> <name><surname>Mohammed</surname> <given-names>N</given-names></name> <name><surname>Schumann</surname> <given-names>A</given-names></name> <name><surname>Weigand</surname> <given-names>K</given-names></name> <name><surname>Kawan</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>Five-year experience with the adjustable transobturator male system for the treatment of male stress urinary incontinence: a single-center evaluation</article-title>. <source>World J Urol.</source> (<year>2017</year>) <volume>35</volume>:<fpage>145</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1007/s00345-016-1839-x</pub-id><pub-id pub-id-type="pmid">27156092</pub-id></citation></ref>
<ref id="B54">
<label>54.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cornel</surname> <given-names>EB</given-names></name></person-group>. <article-title>Argus-T adjustable male sling: the influence of surgical technique on complications and short-term efficacy</article-title>. <source>Urol Int</source>. (<year>2016</year>) <volume>96</volume>:<fpage>164</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1159/000443673</pub-id><pub-id pub-id-type="pmid">26780553</pub-id></citation></ref>
<ref id="B55">
<label>55.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname> <given-names>JP</given-names></name> <name><surname>Pompeo</surname> <given-names>AC</given-names></name> <name><surname>Bezerra</surname> <given-names>CA</given-names></name></person-group>. <article-title>Argus T(R) versus Advance(R) Sling for postprostatectomy urinary incontinence: a randomized clinical trial</article-title>. <source>Int Braz J Urol.</source> (<year>2016</year>) <volume>42</volume>:<fpage>531</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1590/S1677-5538.IBJU.2015.0075</pub-id><pub-id pub-id-type="pmid">27286117</pub-id></citation></ref>
<ref id="B56">
<label>56.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leizour</surname> <given-names>B</given-names></name> <name><surname>Chevrot</surname> <given-names>A</given-names></name> <name><surname>Wagner</surname> <given-names>L</given-names></name> <name><surname>Droupy</surname> <given-names>S</given-names></name> <name><surname>Costa</surname> <given-names>P</given-names></name></person-group>. <article-title>Adjustable retropubic suburethral sling Remeex(&#x000AE;) in the treatment of male stress urinary incontinence: one-year results</article-title>. <source>Prog Urol.</source> (<year>2017</year>) <volume>27</volume>:<fpage>238</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.purol.2016.11.006</pub-id><pub-id pub-id-type="pmid">28043779</pub-id></citation></ref>
<ref id="B57">
<label>57.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trigo Rocha</surname> <given-names>F</given-names></name> <name><surname>Gomes</surname> <given-names>CM</given-names></name> <name><surname>Mitre</surname> <given-names>AI</given-names></name> <name><surname>Arap</surname> <given-names>S</given-names></name> <name><surname>Srougi</surname> <given-names>M</given-names></name></person-group>. <article-title>A prospective study evaluating the efficacy of the artificial sphincter AMS 800 for the treatment of postradical prostatectomy urinary incontinence and the correlation between preoperative urodynamic and surgical outcomes</article-title>. <source>Urology</source>. (<year>2008</year>) <volume>71</volume>:<fpage>85</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.urology.2007.09.009</pub-id><pub-id pub-id-type="pmid">18242371</pub-id></citation></ref>
<ref id="B58">
<label>58.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaiho</surname> <given-names>Y</given-names></name> <name><surname>Masuda</surname> <given-names>H</given-names></name> <name><surname>Takei</surname> <given-names>M</given-names></name> <name><surname>Hirayama</surname> <given-names>T</given-names></name> <name><surname>Mitsui</surname> <given-names>T</given-names></name> <name><surname>Yokoyama</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Surgical and patient reported outcomes of artificial urinary sphincter implantation: a multicenter, prospective, observational study</article-title>. <source>J Urol.</source> (<year>2018</year>) <volume>199</volume>:<fpage>245</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.juro.2017.08.077</pub-id><pub-id pub-id-type="pmid">28823767</pub-id></citation></ref>
<ref id="B59">
<label>59.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yiou</surname> <given-names>R</given-names></name> <name><surname>Butow</surname> <given-names>Z</given-names></name> <name><surname>Baron</surname> <given-names>T</given-names></name> <name><surname>Salomon</surname> <given-names>L</given-names></name> <name><surname>Audureau</surname> <given-names>E</given-names></name></person-group>. <article-title>Adjustable continence therapy (ProACT) after male sling failure for patients with post-radical prostatectomy urinary incontinence: a prospective study with one-year follow-up</article-title>. <source>World J Urol.</source> (<year>2015</year>) <volume>33</volume>:<fpage>1331</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/s00345-014-1447-6</pub-id></citation></ref>
<ref id="B60">
<label>60.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crivellaro</surname> <given-names>S</given-names></name> <name><surname>Singla</surname> <given-names>A</given-names></name> <name><surname>Aggarwal</surname> <given-names>N</given-names></name> <name><surname>Frea</surname> <given-names>B</given-names></name> <name><surname>Kocjancic</surname> <given-names>E</given-names></name></person-group>. <article-title>Adjustable continence therapy (ProACT) and bone anchored male sling: comparison of two new treatments of post prostatectomy incontinence</article-title>. <source>Int J Urol.</source> (<year>2008</year>) <volume>15</volume>:<fpage>910</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1111/j.1442-2042.2008.02161.x</pub-id><pub-id pub-id-type="pmid">18761534</pub-id></citation></ref>
<ref id="B61">
<label>61.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Toia</surname> <given-names>B</given-names></name> <name><surname>Gresty</surname> <given-names>H</given-names></name> <name><surname>Pakzad</surname> <given-names>M</given-names></name> <name><surname>Hamid</surname> <given-names>R</given-names></name> <name><surname>Ockrim</surname> <given-names>J</given-names></name> <name><surname>Greenwell</surname> <given-names>T</given-names></name></person-group>. <article-title>Bulking for stress urinary incontinence in men: a systematic review</article-title>. <source>Neurourol Urodyn</source>. (<year>2019</year>) <volume>38</volume>:<fpage>1804</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1002/nau.24102</pub-id><pub-id pub-id-type="pmid">31321804</pub-id></citation></ref>
<ref id="B62">
<label>62.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chughtai</surname> <given-names>B</given-names></name> <name><surname>Sedrakyan</surname> <given-names>A</given-names></name> <name><surname>Isaacs</surname> <given-names>AJ</given-names></name> <name><surname>Mao</surname> <given-names>J</given-names></name> <name><surname>Lee</surname> <given-names>R</given-names></name> <name><surname>Te</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>National study of utilization of male incontinence procedures</article-title>. <source>Neurourol Urodyn</source>. (<year>2016</year>) <volume>35</volume>:<fpage>74</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1002/nau.22683</pub-id><pub-id pub-id-type="pmid">25327701</pub-id></citation></ref>
<ref id="B63">
<label>63.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rehder</surname> <given-names>P</given-names></name> <name><surname>Gozzi</surname> <given-names>C</given-names></name></person-group>. <article-title>Transobturator sling suspension for male urinary incontinence including post-radical prostatectomy</article-title>. <source>Eur Urol</source>. (<year>2007</year>) <volume>52</volume>:<fpage>860</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2007.01.110</pub-id><pub-id pub-id-type="pmid">17316969</pub-id></citation></ref>
<ref id="B64">
<label>64.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname> <given-names>RM</given-names></name> <name><surname>Grabbert</surname> <given-names>MT</given-names></name> <name><surname>Klehr</surname> <given-names>B</given-names></name> <name><surname>Gebhartl</surname> <given-names>P</given-names></name> <name><surname>Gozzi</surname> <given-names>C</given-names></name> <name><surname>Homberg</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>36-month data for the AdVance XP(R) male sling: results of a prospective multicentre study</article-title>. <source>BJU Int</source>. (<year>2017</year>) <volume>119</volume>:<fpage>626</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1111/bju.13704</pub-id><pub-id pub-id-type="pmid">29144933</pub-id></citation></ref>
<ref id="B65">
<label>65.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meisterhofer</surname> <given-names>K</given-names></name> <name><surname>Herzog</surname> <given-names>S</given-names></name> <name><surname>Strini</surname> <given-names>KA</given-names></name> <name><surname>Sebastianelli</surname> <given-names>L</given-names></name> <name><surname>Bauer</surname> <given-names>R</given-names></name> <name><surname>Dalpiaz</surname> <given-names>O</given-names></name></person-group>. <article-title>Male slings for postprostatectomy incontinence: a systematic review and meta-analysis</article-title>. <source>Eur Urol Focus.</source> (<year>2020</year>) <volume>6</volume>:<fpage>575</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.euf.2019.01.008</pub-id><pub-id pub-id-type="pmid">32972897</pub-id></citation></ref>
<ref id="B66">
<label>66.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Esquinas</surname> <given-names>C</given-names></name> <name><surname>Angulo</surname> <given-names>JC</given-names></name></person-group>. <article-title>Effectiveness of Adjustable Transobturator Male System (ATOMS) to Treat Male Stress Incontinence: a systematic review and meta-analysis</article-title>. <source>Adv Ther.</source> (<year>2019</year>) <volume>36</volume>:<fpage>426</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1007/s12325-018-0852-4</pub-id><pub-id pub-id-type="pmid">30560525</pub-id></citation></ref>
<ref id="B67">
<label>67.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>H&#x000FC;sch</surname> <given-names>T</given-names></name> <name><surname>Kretschmer</surname> <given-names>A</given-names></name> <name><surname>Obaje</surname> <given-names>A</given-names></name> <name><surname>Kirschner-Hermanns</surname> <given-names>R</given-names></name> <name><surname>Anding</surname> <given-names>R</given-names></name> <name><surname>Pottek</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Fixed or adjustable sling in the treatment of male stress urinary incontinence: results from a large cohort study</article-title>. <source>Transl Androl Urol.</source> (<year>2020</year>) <volume>9</volume>:<fpage>1099</fpage>&#x02013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.21037/tau-19-852</pub-id></citation>
</ref>
<ref id="B68">
<label>68.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname> <given-names>FB</given-names></name> <name><surname>Bradley</surname> <given-names>WE</given-names></name> <name><surname>Timm</surname> <given-names>GW</given-names></name></person-group>. <article-title>Treatment of urinary incontinence by an implantable prosthetic urinary sphincter</article-title>. <source>J Urol</source>. (<year>1974</year>) <volume>112</volume>:<fpage>75</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5347(17)59647-0</pub-id></citation>
</ref>
<ref id="B69">
<label>69.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leicht</surname> <given-names>W</given-names></name> <name><surname>Thuroff</surname> <given-names>J</given-names></name></person-group>. <article-title>Therapy of male urinary incontinence: artificial sphincter versus male slings</article-title>. <source>Der Urologe Ausg A.</source> (<year>2012</year>) <volume>51</volume>:<fpage>341</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1007/s00120-012-2820-y</pub-id><pub-id pub-id-type="pmid">22399110</pub-id></citation></ref>
<ref id="B70">
<label>70.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van der Aa</surname> <given-names>F</given-names></name> <name><surname>Drake</surname> <given-names>MJ</given-names></name> <name><surname>Kasyan</surname> <given-names>GR</given-names></name> <name><surname>Petrolekas</surname> <given-names>A</given-names></name> <name><surname>Cornu</surname> <given-names>JN</given-names></name></person-group>. <article-title>The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence</article-title>. <source>Eur Urol</source>. (<year>2013</year>) <volume>63</volume>:<fpage>681</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2012.11.034</pub-id><pub-id pub-id-type="pmid">26699985</pub-id></citation></ref>
<ref id="B71">
<label>71.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>H&#x000FC;sch</surname> <given-names>T</given-names></name> <name><surname>Kretschmer</surname> <given-names>A</given-names></name> <name><surname>Thomsen</surname> <given-names>F</given-names></name> <name><surname>Kronlachner</surname> <given-names>D</given-names></name> <name><surname>Kurosch</surname> <given-names>M</given-names></name> <name><surname>Obaje</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Risk factors for failure of male slings and artificial urinary sphincters: results from a large middle european cohort study</article-title>. <source>Urol Int</source>. (<year>2017</year>) <volume>99</volume>:<fpage>14</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1159/000449232</pub-id><pub-id pub-id-type="pmid">27598774</pub-id></citation></ref>
<ref id="B72">
<label>72.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crivellaro</surname> <given-names>S</given-names></name> <name><surname>Morlacco</surname> <given-names>A</given-names></name> <name><surname>Bodo</surname> <given-names>G</given-names></name> <name><surname>Agro</surname> <given-names>EF</given-names></name> <name><surname>Gozzi</surname> <given-names>C</given-names></name> <name><surname>Pistolesi</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Systematic review of surgical treatment of post radical prostatectomy stress urinary incontinence</article-title>. <source>Neurourol Urodyn.</source> (<year>2016</year>) <volume>35</volume>:<fpage>875</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1002/nau.22873</pub-id><pub-id pub-id-type="pmid">26397171</pub-id></citation></ref>
<ref id="B73">
<label>73.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parsons</surname> <given-names>BA</given-names></name> <name><surname>Evans</surname> <given-names>S</given-names></name> <name><surname>Wright</surname> <given-names>MP</given-names></name></person-group>. <article-title>Prostate cancer and urinary incontinence</article-title>. <source>Maturitas</source>. (<year>2009</year>) <volume>63</volume>:<fpage>323</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.maturitas.2009.06.005</pub-id></citation></ref>
<ref id="B74">
<label>74.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tantawy</surname> <given-names>SA</given-names></name> <name><surname>Elgohary</surname> <given-names>HMI</given-names></name> <name><surname>Abdelbasset</surname> <given-names>WK</given-names></name> <name><surname>Kamel</surname> <given-names>DM</given-names></name></person-group>. <article-title>Effect of 4 weeks of whole-body vibration training in treating stress urinary incontinence after prostate cancer surgery: a randomised controlled trial</article-title>. <source>Physiotherapy</source>. (<year>2019</year>) <volume>105</volume>:<fpage>338</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.physio.2018.07.013</pub-id><pub-id pub-id-type="pmid">30630622</pub-id></citation></ref>
<ref id="B75">
<label>75.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitterberger</surname> <given-names>M</given-names></name> <name><surname>Marksteiner</surname> <given-names>R</given-names></name> <name><surname>Margreiter</surname> <given-names>E</given-names></name> <name><surname>Pinggera</surname> <given-names>GM</given-names></name> <name><surname>Frauscher</surname> <given-names>F</given-names></name> <name><surname>Ulmer</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Myoblast and fibroblast therapy for post-prostatectomy urinary incontinence: 1-year followup of 63 patients</article-title>. <source>J Urol.</source> (<year>2008</year>) <volume>179</volume>:<fpage>226</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.juro.2007.08.154</pub-id><pub-id pub-id-type="pmid">18001790</pub-id></citation></ref>
<ref id="B76">
<label>76.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gotoh</surname> <given-names>M</given-names></name> <name><surname>Yamamoto</surname> <given-names>T</given-names></name> <name><surname>Kato</surname> <given-names>M</given-names></name> <name><surname>Majima</surname> <given-names>T</given-names></name> <name><surname>Toriyama</surname> <given-names>K</given-names></name> <name><surname>Kamei</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Regenerative treatment of male stress urinary incontinence by periurethral injection of autologous adipose-derived regenerative cells: 1-year outcomes in 11 patients</article-title>. <source>Int J Urol.</source> (<year>2014</year>) <volume>21</volume>:<fpage>294</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1111/iju.12266</pub-id><pub-id pub-id-type="pmid">26852992</pub-id></citation></ref>
<ref id="B77">
<label>77.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Apostolidis</surname> <given-names>A</given-names></name> <name><surname>Dasgupta</surname> <given-names>P</given-names></name> <name><surname>Denys</surname> <given-names>P</given-names></name> <name><surname>Elneil</surname> <given-names>S</given-names></name> <name><surname>Fowler</surname> <given-names>CJ</given-names></name> <name><surname>Giannantoni</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report</article-title>. <source>Eur Urol.</source> (<year>2009</year>) <volume>55</volume>:<fpage>100</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2008.09.009</pub-id><pub-id pub-id-type="pmid">19876612</pub-id></citation></ref>
</ref-list>
</back>
</article>